The Performance Effects of Congruence between Product Competitive Strategies and Purchasing Management Design

Autor: David, Julie Smith, Hwang, Yuhchang, Reneau, J. Hal

Publikováno v: Management Science, 2002 Jul 01. 48(7), 866-885.

Externí odkaz: https://www.jstor.org/stable/822696

Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.

Autor: Braunstein Z; Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Waller A; Department of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., Dotson E; Department of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA., McLaughlin E; Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA., Hanel W; Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Reneau J; Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Addison D; Cardio-Oncology Program, Division of Cardiology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Porcu P; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Sydney Kimmel Cancer Center, Thomas Jefferson University, PA, USA., Brammer JE; Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 301-311. Date of Electronic Publication: 2023 Dec 13.

Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program.

Autor: Weiss J; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Gibbons K; Department of Pathology, Henry Ford Hospital, Detroit, Michigan., Ehyaee V; Department of Pathology, Rush University, Chicago, Illinois., Perez-Silos V; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois., Zevallos A; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois., Maienschein-Cline M; Research Informatics Core, University of Illinois at Chicago, Chicago, Illinois., Brister E; Research Tissue Imaging Core and Research Histology Core, University of Illinois at Chicago, Chicago, Illinois., Sverdlov M; Research Tissue Imaging Core and Research Histology Core, University of Illinois at Chicago, Chicago, Illinois., Shah E; Department of Internal Medicine, University of Illinois at Chicago, Chicago, Illinois., Balakrishna J; Department of Pathology, Ohio State University, Columbus, Ohio., Symes E; Department of Pathology, University of Chicago, Chicago, Illinois., Frederiksen JK; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois., Gann PH; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois., Post R; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois., Lopez-Hisijos N; Department of Pathology, Rush University, Chicago, Illinois., Reneau J; Department of Internal Medicine, Ohio State University, Columbus, Ohio., Venkataraman G; Department of Pathology, University of Chicago, Chicago, Illinois., Bailey N; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Brown NA; Department of Pathology, University of Michigan, Ann Arbor, Michigan., Xu ML; Department of Pathology, Yale University, New Haven, Connecticut., Wilcox RA; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan., Inamdar K; Department of Pathology, Henry Ford Hospital, Detroit, Michigan. Electronic address: kinamda1@hfhs.org., Murga-Zamalloa C; Department of Pathology, University of Illinois at Chicago, Chicago, Illinois. Electronic address: catto@uic.edu.

Publikováno v: The American journal of pathology [Am J Pathol] 2024 Jan; Vol. 194 (1), pp. 165-178. Date of Electronic Publication: 2023 Nov 03.

Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.

Autor: Epperla N; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA. Narendranath.Epperla@osumc.edu., Feng L; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shah NN; Medical College of Wisconsin, Milwaukee, WI, USA., Fitzgerald L; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Shah H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Stephens DM; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Lee CJ; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Fred Hutchinson Cancer Center, University of Washington Medical Center, Seattle, WA, USA., Ollila T; Lifespan Cancer Institute, Brown University, Providence, RI, USA., Shouse G; City of Hope National Medical Center, Duarte, CA, USA., Danilov AV; City of Hope National Medical Center, Duarte, CA, USA., David KA; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Torka P; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Hashmi H; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Hess B; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA., Barta SK; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Romancik JT; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Cohen JB; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Annunzio K; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA., Kittai AS; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA., Reneau J; Division of Hematology, Department of Medicine, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH, 43210, USA., Zurko J; Medical College of Wisconsin, Milwaukee, WI, USA., Nizamuddin IA; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Winter JN; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Gordon LI; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Ma S; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Patel R; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nastoupil L; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ahmed S; University of Texas MD Anderson Cancer Center, Houston, TX, USA. SAhmed3@mdanderson.org., Karmali R; Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.

Publikováno v: Journal of hematology & oncology [J Hematol Oncol] 2023 Nov 09; Vol. 16 (1), pp. 111. Date of Electronic Publication: 2023 Nov 09.

Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy

Autor: Girard J, Reneau J, Devata S, Wilcox RA, Kaminski MS, Mercer J, Carty S, Phillips TJ

Publikováno v: OncoTargets and Therapy, Vol Volume 12, Pp 8003-8014 (2019)

Jennifer Girard, John Reneau, Sumana Devata, Ryan A Wilcox, Mark S Kaminski, Jessica Mercer, Shannon Carty, Tycel J Phillips Department of Internal Medicine, Division of Hematology-Oncology, Rogel Cancer Center University of Michigan, Ann Arbor, MI,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::7992101cf9636dfc845ee3355aa1224c
https://www.dovepress.com/evaluating-acalabrutinib-in-the-treatment-of-mantle-cell-lymphoma-desi-peer-reviewed-article-OTT